INDEMNIFICATION AGREEMENTIndemnification Agreement • March 6th, 2023 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 6th, 2023 Company Industry JurisdictionTHIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of ____________ between Oramed Pharmaceuticals Inc., a Delaware corporation (the “Company”), and __________ (“Indemnitee”).
Employment AgreementEmployment Agreement • March 6th, 2023 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledMarch 6th, 2023 Company IndustryThis Employment Agreement is made effective as of the 1st day of November 2022, by and between Nadav Kidron, an individual residing in Jerusalem, Israel (the “Executive”), and ORAMED Ltd., a company incorporated under the laws of the State of Israel, with an address at 20 Mamilla Ave., Jerusalem, Israel (the “Company”).
Second Amendment to Employment AgreementEmployment Agreement • March 6th, 2023 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledMarch 6th, 2023 Company IndustryThis Second Amendment to Employment Agreement (this “Second Amendment”) is entered into as of this 25th day of October 2022 and is effective as of January 1, 2023, by and between David Silberman, an individual residing in Jerusalem, Israel (the “Executive”), and Oramed Ltd., a company incorporated under the laws of the State of Israel, with an address at 20 Mamilla Ave., Jerusalem, Israel 9414904 (the “Company”).
STOCK OPTION AGREEMENT ORAVAX MEDICAL, INC.Stock Option Agreement • March 6th, 2023 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledMarch 6th, 2023 Company Industry
CONSULTING AGREEMENTConsulting Agreement • March 6th, 2023 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledMarch 6th, 2023 Company IndustryThis Consulting Agreement (this “Agreement”) is made effective as of November 1, 2022, by and between Oramed Pharmaceuticals Inc., a company incorporated under the laws of the State of Delaware, with an address at 20 Mamilla Ave., Jerusalem, Israel 9414904 (the “Company”) and Shnida Ltd., a company incorporated under the laws of the State of Israel, (company I.D. no. 514519016) with an address at 32 Eliezer Hagadol Street, Jerusalem (the “Consultant”).